Upper Limb Blood Flow Restriction in Handball Players
Efficacy of Upper Limb Blood Flow Restriction in Handball Players. Randomised Clinical Study
1 other identifier
interventional
22
1 country
1
Brief Summary
Introduction. Blood flow restriction therapy involves the use of an occlusion cuff placed over an extremity resulting in a partial reduction of arterial blood flow and total restriction of venous return. Objectives. To analyse the efficacy of a physiotherapy intervention using blood flow restriction in improving upper limb strength in adult handball players. Methods. Randomised, single-blind, clinical study. 20 athletes will be recruited and randomly assigned to the experimental and control groups. The intervention of the experimental group will consist of performing an exercise protocol after blood flow restriction. The intervention period will last 4 weeks, with a periodicity of 2 weekly sessions of 30 minutes each. The primary variable will be the strength of the triceps, epicondyle and epitrochlear musculature (pressure hand dynamometer). The secondary variable will be the muscle activation of this musculature (surface electromyography).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 15, 2024
CompletedStudy Start
First participant enrolled
May 19, 2024
CompletedFirst Posted
Study publicly available on registry
May 21, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 15, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2024
CompletedMarch 25, 2025
May 1, 2024
27 days
May 15, 2024
March 24, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Assess the muscle strength at screening visit
Muscle strength will be assessed with a pressure dynamometer (Lafayette Manual Muscle model). The strength of the triceps brachii, epicondyle and epitrochlear musculature will be measured. The evaluation protocol used by Morin et al. will be used. The unit of measurement is the Newton (the higher the value, the greater the muscle strength). The measurements are taken bilaterally. The mean value of the 2 measurements taken shall be used as a measure.
Screening visit, within the first seven days after treatment and after four weeks follow-up
Secondary Outcomes (1)
Assess the muscle activation at screening visit
Screening visit, within the first seven days after treatment and after four weeks follow-up
Study Arms (2)
Experimental group
EXPERIMENTALThe intervention of the experimental group will consist of performing an exercise protocol after carrying out the blood flow restriction. A total of 6 muscle strength exercises will be performed for the proximal (triceps brachii) and forearm (epitrochlear and epicondylar muscles).
Control group
NO INTERVENTIONPatients included in the control group will continue with their pre-study training and activities, without modifying their routine.
Interventions
In the development of the exercises, the players will mobilise dumbbells of different weights that will be estimated according to the calculation of 30% of 1 RM. This workload with dumbbells is based on previous work where blood flow restriction was used in healthy athletes.
Eligibility Criteria
You may qualify if:
- Athletes over 18 years of age.
- Federated in handball at the time of the study.
- No lower limb injuries in the three months prior to the study.
- Signing the informed consent document.
You may not qualify if:
- Athletes who have undergone surgery in the year prior to the study.
- People who do not attend at least 80% of the treatment sessions.
- Players who are receiving physiotherapy treatment in parallel to the physical preparation of the team they are playing for.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Universidad Católica San Antonio, Murcia
Murcia, 30107, Spain
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Three assessments will be made throughout the study: before the intervention (T0), after the experimental phase (T1) and after a 4-week follow-up period (T2). All variables will be assessed by an evaluator blinded to the assignment of the athletes to the study groups.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
May 15, 2024
First Posted
May 21, 2024
Study Start
May 19, 2024
Primary Completion
June 15, 2024
Study Completion
July 1, 2024
Last Updated
March 25, 2025
Record last verified: 2024-05